Assisted reproductive technologies at the nexus of fertility treatment and disease prevention
Author(s) -
Mary Herbert,
Meenakshi Choudhary,
Deirdre Zander-Fox
Publication year - 2023
Publication title -
science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 12.556
H-Index - 1186
eISSN - 1095-9203
pISSN - 0036-8075
DOI - 10.1126/science.adh0073
Subject(s) - infertility , in vitro fertilisation , assisted reproductive technology , fertility , biology , scope (computer science) , reproductive technology , nexus (standard) , disease , genetic testing , human reproduction , embryo , bioinformatics , microbiology and biotechnology , medicine , genetics , environmental health , pregnancy , computer science , cryopreservation , population , embedded system , programming language
Assisted reproductive technology (ART) refers to processing gametes in vitro and usually involves in vitro fertilization. Originally developed for the treatment of infertility, culture of human embryos in vitro also provides an opportunity to screen embryos for inherited genetic disorders of the nuclear and mitochondrial genomes. Progress in identifying causative genetic variants has massively increased the scope of preimplantation genetic testing in preventing genetic disorders. However, because ART procedures are not without risk of adverse maternal and child outcomes, careful consideration of the balance of risks and benefits is warranted. Further research on early human development will help to minimize risks while maximizing the benefits of ART.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom